Overview
Terumo Blood and Cell Technologies provides medical technologies for blood collection, processing, and cell-based therapies, including apheresis systems, blood bags, and automated cell expansion solutions like the Quantum system. They support hospitals, blood centers, researchers, and cell therapy developers with products for whole blood separation, pathogen reduction, and CAR-T cell manufacturing. Their offerings enhance efficiency in therapeutic apheresis and enable scalable cell and gene therapies globally.
Frequently asked questions
- What are Terumo BCT's key capabilities in cell therapy manufacturing?
- They offer automated systems like the Quantum Cell Expansion System for T cell activation, lentiviral transduction, and CAR-T cell expansion, achieving over 12 billion cells in 7-8 days with doubled transduction efficiency.
- What regulatory standards do Terumo BCT products meet?
- Their solutions support high-quality care for blood transfusions and advanced therapies, with a focus on standards for quality, efficiency, and patient access in hospitals, blood centers, and cell therapy development.
- In which geographies does Terumo BCT operate?
- They provide global support, including a dedicated C> Ecosystem Blueprint for the Asia-Pacific region, alongside operations in North America and worldwide for blood and cell technologies.